In order to obtain a more precise estimation of this relationship, we performed this meta-analysis including 19 case-control studies with 4,162 cases and 5,173 controls, and the result demonstrated that the MCP-1 −2518A/G polymorphism was not associated with cancer susceptibility in overall analysis. The gene discussed is CCL2; the disease is cancer.